U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Hartmann KE, McPheeters ML, Biller DH, et al. Treatment of Overactive Bladder in Women. Rockville (MD): Agency for Healthcare Research and Quality (US); 2009 Aug. (Evidence Reports/Technology Assessments, No. 187.)

  • This publication is provided for historical reference only and the information may be out of date.

This publication is provided for historical reference only and the information may be out of date.

Cover of Treatment of Overactive Bladder in Women

Treatment of Overactive Bladder in Women.

Show details

List of Acronyms/Abbreviations

±

plus or minus

less than or equal to

greater than or equal to

AE

adverse events

AHCPR

Agency for Health Care Policy and Research

AHRQ

Agency for Healthcare Research and Quality

AUC

area under the curve

AUM

ambulatory urodynamic monitoring

avg.

average

BAPFMT

biofeedback-assisted pelvic floor muscle training

BFQ

Bladder Function Questionnaire

b.i.d.

twice a day

BL

baseline

BM

bowel movements

BMI

body mass index

BOO

bladder outlet obstruction

BPH

benign prostatic hyperplasia

bpm

beats per minute

BRD

bladder retraining drill

BT

bladder training

CEE

Conjugated equine estrogens

CHF

Congestive heart failure

CI

confidence interval(s)

cm

centimeter

cmH2O

centimeters of water

CR

controlled release

CS

cognitive strategies

CT

combination therapy

CUBS

Compromised urinary bladder syndrome

d

day

d/t

drug treatment

DI

Detrusor instability

dL

deciliter

DM

Diabetes mellitus

DO

detrusor overactivity

Dx

diagnosis

EKG

electrocardiogram

ER

extended release

ES

electrical stimulation (electrostimulation)

etc.

et cetera

EtOH

Ethanol (alcohol)

F

F-distribution

G

group

GI

gastrointestinal

GII

global impression of improvement

GSI

genuine stress incontinence

GU

genitourinary

HAD

Hospital Anxiety and Depression Scale

H2O

water

hr(s)

hour(s)

HRQoL

Health related quality of life

HRT

hormone replacement therapy

Hx

history

Hz

hertz

IBD

irritable bowel disease

IC

interstitial cystitis

ICIQ

International Consultation on Incontinence Modular Questionnaire

ICIQ-SF

International Consultation on Incontinence Questionnaire-Short Form

IIQ

Incontinence Impact Questionnaire

IIQ-R

Incontinence Impact Questionnaire-Revised

IMPACT

Improvement in Patients: Assessing symptomatic control with tolterodine

IQR

interquartile range

IR

immediate release

ITT

intention to treat

IUSS

Indevus Urgency Severity Scale

KQ

key question

kg/m2

kilograms per meter squared

KHQ

King’s Health Questionnaire

L

liter

LCB

low-compliance bladder

LOCF

last observation carried forward

LOS

length of stay

LS

least square

Ltd

limited

LTFU

Loss to followup

LUT

Lower urinary tract

LUTS

Lower urinary tract syndrome

mg

milligram

min

minute(s)

mL

milliliter

mL/s

milliliters per second

mm

millimeter

MMSE

Mini Mental Status Exam

mo(s)

month(s)

MUI

Mixed urinary incontinence

MVV

Mean volume voided

n, N

number

ng

nanogram

NIH

National Institutes of Health

NR

not reported

NS

Not significant

OAB

Overactive bladder

OAB-q

OAB questionnaire

OAB-SCS

OAB-Symptom Composite Score

OCAS

oral controlled absorption system

P, p

p value

PFME

pelvic floor muscle exercises

PFMT

pelvic floor muscle training

PGA

patient-reported goal achievement

PISQ

Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire

PME

pelvic muscle exercises

PNN50

measure of heart rate variability

P.O.

per oral (by mouth)

PPBC

Patient perception of bladder condition

PPBCS

Patient perception of bladder condition scale

PPIUS

Patient Perception of Intensity of Urgency Scale

PPPY

per person per year

PRO

Patient reported outcome(s)

Pt

patient

PVR

post-void residual

qAM

every morning

qd

every day

qid

four times per day

QoL

quality of life

QTcB

QT interval correct for heart rate using Bazett’s formula

RCT

randomized controlled trial

RTX

resiniferatoxin

s

second

SCL-90-R

Symptom Checklist-90-Revised

SD

standard deviation

SE

standard error

SF

Sexual function

sec

second

SNM

sacroneuromodulation

SQoL-F

Sexual Quality of Life Questionnaire-Female

subj.

subjects

SUI

Stress urinary incontinence

Sx

symptoms

t.i.d.

three times a day

TDS

transdermal delivery system

UDI

Urogenital Distress Inventory

UDS

urodynamics

UFICQ

Urinary Frequency and Incontinence Questionnaire

UI

urinary incontinence

US

United States

UTI

urinary tract infection

UUDI

Urge Urogenital Distress Inventory

UUI

Urge urinary incontinence

VAS

visual analog scale

vs., v

versus

w/

with

wk(s)

week(s)

x

times

yr(s)

year(s)

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (8.3M)

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...